nodes	percent_of_prediction	percent_of_DWPC	metapath
Levothyroxine—SLCO1A2—Spironolactone—dilated cardiomyopathy	0.363	0.429	CbGbCtD
Levothyroxine—CYP2C8—Spironolactone—dilated cardiomyopathy	0.145	0.171	CbGbCtD
Levothyroxine—ALB—Furosemide—dilated cardiomyopathy	0.128	0.152	CbGbCtD
Levothyroxine—ABCB1—Lisinopril—dilated cardiomyopathy	0.111	0.132	CbGbCtD
Levothyroxine—ABCB1—Spironolactone—dilated cardiomyopathy	0.098	0.116	CbGbCtD
Levothyroxine—Menstruation irregular—Spironolactone—dilated cardiomyopathy	0.00871	0.109	CcSEcCtD
Levothyroxine—THRA—Nuclear Receptor transcription pathway—NR3C2—dilated cardiomyopathy	0.00415	0.0563	CbGpPWpGaD
Levothyroxine—THRB—Nuclear Receptor transcription pathway—NR3C2—dilated cardiomyopathy	0.00415	0.0563	CbGpPWpGaD
Levothyroxine—TTR—Non-integrin membrane-ECM interactions—LAMA4—dilated cardiomyopathy	0.00407	0.0551	CbGpPWpGaD
Levothyroxine—TTR—Non-integrin membrane-ECM interactions—DMD—dilated cardiomyopathy	0.00269	0.0365	CbGpPWpGaD
Levothyroxine—THRB—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.00245	0.0332	CbGpPWpGaD
Levothyroxine—THRB—RXR and RAR heterodimerization with other nuclear receptor—RPS6KB1—dilated cardiomyopathy	0.00241	0.0327	CbGpPWpGaD
Levothyroxine—THRA—RXR and RAR heterodimerization with other nuclear receptor—RPS6KB1—dilated cardiomyopathy	0.00241	0.0327	CbGpPWpGaD
Levothyroxine—SLC7A5—Basigin interactions—ITGB1—dilated cardiomyopathy	0.00238	0.0322	CbGpPWpGaD
Levothyroxine—Alopecia—Spironolactone—dilated cardiomyopathy	0.00214	0.0268	CcSEcCtD
Levothyroxine—Wheezing—Lisinopril—dilated cardiomyopathy	0.00191	0.024	CcSEcCtD
Levothyroxine—Irritability—Furosemide—dilated cardiomyopathy	0.00182	0.0228	CcSEcCtD
Levothyroxine—Dehydration—Furosemide—dilated cardiomyopathy	0.00177	0.0222	CcSEcCtD
Levothyroxine—THRB—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.00175	0.0237	CbGpPWpGaD
Levothyroxine—Confusional state—Spironolactone—dilated cardiomyopathy	0.00173	0.0218	CcSEcCtD
Levothyroxine—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00168	0.0211	CcSEcCtD
Levothyroxine—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00146	0.0184	CcSEcCtD
Levothyroxine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00142	0.0178	CcSEcCtD
Levothyroxine—Sweating—Furosemide—dilated cardiomyopathy	0.00141	0.0176	CcSEcCtD
Levothyroxine—Urticaria—Spironolactone—dilated cardiomyopathy	0.00137	0.0171	CcSEcCtD
Levothyroxine—Irritability—Lisinopril—dilated cardiomyopathy	0.00136	0.0171	CcSEcCtD
Levothyroxine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00136	0.0171	CcSEcCtD
Levothyroxine—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00136	0.017	CcSEcCtD
Levothyroxine—Dehydration—Lisinopril—dilated cardiomyopathy	0.00133	0.0167	CcSEcCtD
Levothyroxine—TTR—Non-integrin membrane-ECM interactions—ITGB1—dilated cardiomyopathy	0.00132	0.0178	CbGpPWpGaD
Levothyroxine—TTR—Amyloids—NPPA—dilated cardiomyopathy	0.0013	0.0176	CbGpPWpGaD
Levothyroxine—Pruritus—Spironolactone—dilated cardiomyopathy	0.00122	0.0153	CcSEcCtD
Levothyroxine—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.0012	0.0151	CcSEcCtD
Levothyroxine—Sweating increased—Lisinopril—dilated cardiomyopathy	0.0012	0.0151	CcSEcCtD
Levothyroxine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00118	0.0148	CcSEcCtD
Levothyroxine—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00118	0.0148	CcSEcCtD
Levothyroxine—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00112	0.014	CcSEcCtD
Levothyroxine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00109	0.0137	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00109	0.0136	CcSEcCtD
Levothyroxine—Rash—Spironolactone—dilated cardiomyopathy	0.00108	0.0136	CcSEcCtD
Levothyroxine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00108	0.0136	CcSEcCtD
Levothyroxine—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00108	0.0135	CcSEcCtD
Levothyroxine—Headache—Spironolactone—dilated cardiomyopathy	0.00108	0.0135	CcSEcCtD
Levothyroxine—Sweating—Lisinopril—dilated cardiomyopathy	0.00106	0.0132	CcSEcCtD
Levothyroxine—Agitation—Furosemide—dilated cardiomyopathy	0.00105	0.0132	CcSEcCtD
Levothyroxine—SLCO4A1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.00105	0.0142	CbGpPWpGaD
Levothyroxine—SLCO4C1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.00105	0.0142	CbGpPWpGaD
Levothyroxine—Nausea—Spironolactone—dilated cardiomyopathy	0.00102	0.0128	CcSEcCtD
Levothyroxine—SLC7A5—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.00096	0.013	CbGpPWpGaD
Levothyroxine—Confusional state—Furosemide—dilated cardiomyopathy	0.000944	0.0118	CcSEcCtD
Levothyroxine—THRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—dilated cardiomyopathy	0.000943	0.0128	CbGpPWpGaD
Levothyroxine—THRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—dilated cardiomyopathy	0.000943	0.0128	CbGpPWpGaD
Levothyroxine—TTR—Extracellular matrix organization—LAMA4—dilated cardiomyopathy	0.000934	0.0127	CbGpPWpGaD
Levothyroxine—Shock—Furosemide—dilated cardiomyopathy	0.000921	0.0116	CcSEcCtD
Levothyroxine—Flushing—Lisinopril—dilated cardiomyopathy	0.000917	0.0115	CcSEcCtD
Levothyroxine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000905	0.0114	CcSEcCtD
Levothyroxine—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000883	0.0111	CcSEcCtD
Levothyroxine—SLCO1C1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000879	0.0119	CbGpPWpGaD
Levothyroxine—Alopecia—Lisinopril—dilated cardiomyopathy	0.000873	0.011	CcSEcCtD
Levothyroxine—Tension—Lisinopril—dilated cardiomyopathy	0.000844	0.0106	CcSEcCtD
Levothyroxine—Nervousness—Lisinopril—dilated cardiomyopathy	0.000836	0.0105	CcSEcCtD
Levothyroxine—Fatigue—Furosemide—dilated cardiomyopathy	0.000807	0.0101	CcSEcCtD
Levothyroxine—Tremor—Lisinopril—dilated cardiomyopathy	0.000806	0.0101	CcSEcCtD
Levothyroxine—SLC7A5—Cell surface interactions at the vascular wall—ITGB1—dilated cardiomyopathy	0.00079	0.0107	CbGpPWpGaD
Levothyroxine—Angioedema—Lisinopril—dilated cardiomyopathy	0.000786	0.00986	CcSEcCtD
Levothyroxine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000771	0.00968	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000765	0.0096	CcSEcCtD
Levothyroxine—Palpitations—Lisinopril—dilated cardiomyopathy	0.00076	0.00954	CcSEcCtD
Levothyroxine—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000757	0.0103	CbGpPWpGaD
Levothyroxine—Urticaria—Furosemide—dilated cardiomyopathy	0.000743	0.00933	CcSEcCtD
Levothyroxine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00074	0.00928	CcSEcCtD
Levothyroxine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00074	0.00928	CcSEcCtD
Levothyroxine—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000732	0.00919	CcSEcCtD
Levothyroxine—Anxiety—Lisinopril—dilated cardiomyopathy	0.00073	0.00916	CcSEcCtD
Levothyroxine—THRA—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	0.000718	0.00972	CbGpPWpGaD
Levothyroxine—THRB—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	0.000718	0.00972	CbGpPWpGaD
Levothyroxine—Confusional state—Lisinopril—dilated cardiomyopathy	0.000708	0.00888	CcSEcCtD
Levothyroxine—Shock—Lisinopril—dilated cardiomyopathy	0.000691	0.00867	CcSEcCtD
Levothyroxine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000685	0.0086	CcSEcCtD
Levothyroxine—THRB—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000682	0.00924	CbGpPWpGaD
Levothyroxine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000679	0.00852	CcSEcCtD
Levothyroxine—Asthenia—Furosemide—dilated cardiomyopathy	0.000671	0.00842	CcSEcCtD
Levothyroxine—Pruritus—Furosemide—dilated cardiomyopathy	0.000662	0.00831	CcSEcCtD
Levothyroxine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00064	0.00803	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00064	0.00803	CcSEcCtD
Levothyroxine—Insomnia—Lisinopril—dilated cardiomyopathy	0.000635	0.00797	CcSEcCtD
Levothyroxine—TTR—Extracellular matrix organization—PSEN1—dilated cardiomyopathy	0.000628	0.00851	CbGpPWpGaD
Levothyroxine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000626	0.00785	CcSEcCtD
Levothyroxine—TTR—Extracellular matrix organization—DMD—dilated cardiomyopathy	0.000619	0.00839	CbGpPWpGaD
Levothyroxine—Fatigue—Lisinopril—dilated cardiomyopathy	0.000605	0.00759	CcSEcCtD
Levothyroxine—Vomiting—Furosemide—dilated cardiomyopathy	0.000595	0.00746	CcSEcCtD
Levothyroxine—THRB—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000591	0.00801	CbGpPWpGaD
Levothyroxine—Rash—Furosemide—dilated cardiomyopathy	0.00059	0.0074	CcSEcCtD
Levothyroxine—Dermatitis—Furosemide—dilated cardiomyopathy	0.00059	0.0074	CcSEcCtD
Levothyroxine—Headache—Furosemide—dilated cardiomyopathy	0.000586	0.00736	CcSEcCtD
Levothyroxine—SLC7A5—Hemostasis—TTN—dilated cardiomyopathy	0.000579	0.00785	CbGpPWpGaD
Levothyroxine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000579	0.00726	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000574	0.0072	CcSEcCtD
Levothyroxine—Urticaria—Lisinopril—dilated cardiomyopathy	0.000558	0.007	CcSEcCtD
Levothyroxine—Nausea—Furosemide—dilated cardiomyopathy	0.000556	0.00697	CcSEcCtD
Levothyroxine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000555	0.00696	CcSEcCtD
Levothyroxine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000555	0.00696	CcSEcCtD
Levothyroxine—SLCO4C1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000548	0.00743	CbGpPWpGaD
Levothyroxine—SLCO4A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000548	0.00743	CbGpPWpGaD
Levothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000533	0.00723	CbGpPWpGaD
Levothyroxine—SLCO4C1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000533	0.00723	CbGpPWpGaD
Levothyroxine—SLCO4C1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000533	0.00723	CbGpPWpGaD
Levothyroxine—SLCO4A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000533	0.00723	CbGpPWpGaD
Levothyroxine—SLCO4A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000533	0.00723	CbGpPWpGaD
Levothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000508	0.00689	CbGpPWpGaD
Levothyroxine—ALB—Platelet degranulation—TTN—dilated cardiomyopathy	0.000505	0.00684	CbGpPWpGaD
Levothyroxine—Asthenia—Lisinopril—dilated cardiomyopathy	0.000504	0.00632	CcSEcCtD
Levothyroxine—SLC7A5—Hemostasis—ACTN2—dilated cardiomyopathy	0.000502	0.0068	CbGpPWpGaD
Levothyroxine—SLC7A5—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000501	0.00679	CbGpPWpGaD
Levothyroxine—SLCO1B3—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000498	0.00675	CbGpPWpGaD
Levothyroxine—Pruritus—Lisinopril—dilated cardiomyopathy	0.000497	0.00623	CcSEcCtD
Levothyroxine—SLCO4C1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000496	0.00672	CbGpPWpGaD
Levothyroxine—SLCO4A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000496	0.00672	CbGpPWpGaD
Levothyroxine—SLC7A5—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000488	0.00661	CbGpPWpGaD
Levothyroxine—SLC7A5—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000488	0.00661	CbGpPWpGaD
Levothyroxine—ALB—Response to elevated platelet cytosolic Ca2+—TTN—dilated cardiomyopathy	0.000481	0.00651	CbGpPWpGaD
Levothyroxine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00048	0.00603	CcSEcCtD
Levothyroxine—SLCO1C1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000459	0.00622	CbGpPWpGaD
Levothyroxine—SLC7A5—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000453	0.00614	CbGpPWpGaD
Levothyroxine—THRA—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	0.000451	0.00611	CbGpPWpGaD
Levothyroxine—THRB—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	0.000451	0.00611	CbGpPWpGaD
Levothyroxine—SLCO1C1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000447	0.00606	CbGpPWpGaD
Levothyroxine—SLCO1C1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000447	0.00606	CbGpPWpGaD
Levothyroxine—Vomiting—Lisinopril—dilated cardiomyopathy	0.000446	0.0056	CcSEcCtD
Levothyroxine—Rash—Lisinopril—dilated cardiomyopathy	0.000443	0.00555	CcSEcCtD
Levothyroxine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000442	0.00555	CcSEcCtD
Levothyroxine—Headache—Lisinopril—dilated cardiomyopathy	0.00044	0.00552	CcSEcCtD
Levothyroxine—ALB—Platelet degranulation—ACTN2—dilated cardiomyopathy	0.000437	0.00593	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—VCL—dilated cardiomyopathy	0.000427	0.00579	CbGpPWpGaD
Levothyroxine—Nausea—Lisinopril—dilated cardiomyopathy	0.000417	0.00523	CcSEcCtD
Levothyroxine—ALB—Response to elevated platelet cytosolic Ca2+—ACTN2—dilated cardiomyopathy	0.000417	0.00565	CbGpPWpGaD
Levothyroxine—SLCO1C1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000415	0.00563	CbGpPWpGaD
Levothyroxine—SLCO1A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000391	0.0053	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000384	0.0052	CbGpPWpGaD
Levothyroxine—ALB—Platelet degranulation—VCL—dilated cardiomyopathy	0.000372	0.00504	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000361	0.00489	CbGpPWpGaD
Levothyroxine—ALB—Response to elevated platelet cytosolic Ca2+—VCL—dilated cardiomyopathy	0.000354	0.0048	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—NR3C2—dilated cardiomyopathy	0.000345	0.00468	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—NR3C2—dilated cardiomyopathy	0.000345	0.00468	CbGpPWpGaD
Levothyroxine—SLCO1B1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000335	0.00453	CbGpPWpGaD
Levothyroxine—TTR—Extracellular matrix organization—ITGB1—dilated cardiomyopathy	0.000302	0.0041	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000302	0.00409	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000284	0.00384	CbGpPWpGaD
Levothyroxine—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—dilated cardiomyopathy	0.000272	0.00368	CbGpPWpGaD
Levothyroxine—SLCO1B3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00026	0.00353	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000258	0.0035	CbGpPWpGaD
Levothyroxine—SLCO1B3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000253	0.00343	CbGpPWpGaD
Levothyroxine—SLCO1B3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000253	0.00343	CbGpPWpGaD
Levothyroxine—ALB—Vitamin B12 Metabolism—SOD2—dilated cardiomyopathy	0.000246	0.00333	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000243	0.00329	CbGpPWpGaD
Levothyroxine—CYP2C8—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00024	0.00325	CbGpPWpGaD
Levothyroxine—SLCO1B3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000235	0.00319	CbGpPWpGaD
Levothyroxine—THRB—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000225	0.00305	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.000224	0.00303	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—NPPA—dilated cardiomyopathy	0.000217	0.00294	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—NPPA—dilated cardiomyopathy	0.000217	0.00294	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000214	0.00291	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—ITGB1—dilated cardiomyopathy	0.000214	0.0029	CbGpPWpGaD
Levothyroxine—SLCO1A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000204	0.00277	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—SOD2—dilated cardiomyopathy	0.0002	0.00271	CbGpPWpGaD
Levothyroxine—SLCO1A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000199	0.00269	CbGpPWpGaD
Levothyroxine—SLCO1A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000199	0.00269	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.000194	0.00263	CbGpPWpGaD
Levothyroxine—ALB—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000191	0.00259	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—GPX1—dilated cardiomyopathy	0.000191	0.00259	CbGpPWpGaD
Levothyroxine—SLCO1A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000185	0.0025	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—CD36—dilated cardiomyopathy	0.000183	0.00248	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	0.00018	0.00244	CbGpPWpGaD
Levothyroxine—SLCO1B1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000175	0.00237	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—RAC1—dilated cardiomyopathy	0.000172	0.00233	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—ANKRD1—dilated cardiomyopathy	0.000171	0.00232	CbGpPWpGaD
Levothyroxine—SLCO1B1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00017	0.0023	CbGpPWpGaD
Levothyroxine—SLCO1B1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00017	0.0023	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.000165	0.00224	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—TAZ—dilated cardiomyopathy	0.000161	0.00218	CbGpPWpGaD
Levothyroxine—ALB—Platelet degranulation—CD36—dilated cardiomyopathy	0.000159	0.00216	CbGpPWpGaD
Levothyroxine—ALB—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.000159	0.00215	CbGpPWpGaD
Levothyroxine—SLCO4A1—cardiac ventricle—dilated cardiomyopathy	0.000158	0.105	CbGeAlD
Levothyroxine—SLCO1B1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000158	0.00214	CbGpPWpGaD
Levothyroxine—THRA—heart—dilated cardiomyopathy	0.000156	0.103	CbGeAlD
Levothyroxine—THRB—heart—dilated cardiomyopathy	0.000156	0.103	CbGeAlD
Levothyroxine—ALB—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	0.000152	0.00206	CbGpPWpGaD
Levothyroxine—ALB—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.000152	0.00205	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	0.000151	0.00205	CbGpPWpGaD
Levothyroxine—SLCO4A1—myocardium—dilated cardiomyopathy	0.000149	0.0986	CbGeAlD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000148	0.00201	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000147	0.002	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—SDHA—dilated cardiomyopathy	0.000145	0.00197	CbGpPWpGaD
Levothyroxine—TTR—Disease—NPPA—dilated cardiomyopathy	0.000144	0.00195	CbGpPWpGaD
Levothyroxine—SLC16A2—heart—dilated cardiomyopathy	0.000141	0.0936	CbGeAlD
Levothyroxine—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	0.000141	0.0019	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000139	0.00189	CbGpPWpGaD
Levothyroxine—TTR—Disease—PSEN2—dilated cardiomyopathy	0.000139	0.00188	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000139	0.00188	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	0.000135	0.00184	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000134	0.00182	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—TAZ—dilated cardiomyopathy	0.000126	0.00171	CbGpPWpGaD
Levothyroxine—SLC16A2—cardiac atrium—dilated cardiomyopathy	0.000121	0.0801	CbGeAlD
Levothyroxine—SLC7A5—heart—dilated cardiomyopathy	0.000119	0.0788	CbGeAlD
Levothyroxine—TTR—heart—dilated cardiomyopathy	0.000116	0.0768	CbGeAlD
Levothyroxine—ALB—Hemostasis—TTN—dilated cardiomyopathy	0.000115	0.00156	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000115	0.00156	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—RAF1—dilated cardiomyopathy	0.000114	0.00155	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—SDHA—dilated cardiomyopathy	0.000114	0.00155	CbGpPWpGaD
Levothyroxine—SLCO4C1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000108	0.00147	CbGpPWpGaD
Levothyroxine—SLCO4A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000108	0.00147	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—TAZ—dilated cardiomyopathy	0.000108	0.00146	CbGpPWpGaD
Levothyroxine—SLCO4A1—heart—dilated cardiomyopathy	0.000104	0.0689	CbGeAlD
Levothyroxine—SLC7A5—cardiac atrium—dilated cardiomyopathy	0.000102	0.0674	CbGeAlD
Levothyroxine—ALB—Hemostasis—ACTN2—dilated cardiomyopathy	0.0001	0.00136	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	9.99e-05	0.00135	CbGpPWpGaD
Levothyroxine—SLC7A5—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	9.89e-05	0.00134	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—SDHA—dilated cardiomyopathy	9.77e-05	0.00132	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PSEN2—dilated cardiomyopathy	9.73e-05	0.00132	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	9.71e-05	0.00132	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	9.71e-05	0.00132	CbGpPWpGaD
Levothyroxine—ALB—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	9.32e-05	0.00126	CbGpPWpGaD
Levothyroxine—SLCO1C1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	9.06e-05	0.00123	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	9.03e-05	0.00122	CbGpPWpGaD
Levothyroxine—SLCO4A1—cardiac atrium—dilated cardiomyopathy	8.9e-05	0.0589	CbGeAlD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	8.87e-05	0.0012	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	8.75e-05	0.00119	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—AGTR2—dilated cardiomyopathy	8.64e-05	0.00117	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CXCL2—dilated cardiomyopathy	8.64e-05	0.00117	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	8.64e-05	0.00117	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	8.51e-05	0.00115	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	8.51e-05	0.00115	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—VCL—dilated cardiomyopathy	8.5e-05	0.00115	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CXCR3—dilated cardiomyopathy	8.03e-05	0.00109	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	7.91e-05	0.00107	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—ADRB1—dilated cardiomyopathy	7.78e-05	0.00105	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	7.78e-05	0.00105	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—TNF—dilated cardiomyopathy	7.58e-05	0.00103	CbGpPWpGaD
Levothyroxine—ALB—heart—dilated cardiomyopathy	7.41e-05	0.049	CbGeAlD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	7.06e-05	0.000958	CbGpPWpGaD
Levothyroxine—TTR—Disease—RAC1—dilated cardiomyopathy	6.99e-05	0.000947	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	6.97e-05	0.000944	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	6.93e-05	0.00094	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	6.79e-05	0.00092	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	6.69e-05	0.000906	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	6.66e-05	0.000902	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—AGTR1—dilated cardiomyopathy	6.65e-05	0.000901	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	6.6e-05	0.000895	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ANKRD1—dilated cardiomyopathy	6.56e-05	0.00089	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	6.56e-05	0.000888	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—ADRB2—dilated cardiomyopathy	6.3e-05	0.000854	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	6.21e-05	0.000841	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—TAZ—dilated cardiomyopathy	6.17e-05	0.000836	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.11e-05	0.000828	CbGpPWpGaD
Levothyroxine—ALB—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	6.02e-05	0.000816	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	5.96e-05	0.000808	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	5.8e-05	0.000786	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	5.75e-05	0.00078	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	5.75e-05	0.000779	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	5.61e-05	0.000761	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—SDHA—dilated cardiomyopathy	5.58e-05	0.000756	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.42e-05	0.000734	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	5.41e-05	0.000733	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	5.22e-05	0.000708	CbGpPWpGaD
Levothyroxine—SLCO1B3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.13e-05	0.000695	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—RAC1—dilated cardiomyopathy	4.89e-05	0.000663	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	4.89e-05	0.000663	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—AGT—dilated cardiomyopathy	4.68e-05	0.000634	CbGpPWpGaD
Levothyroxine—TTR—Disease—RAF1—dilated cardiomyopathy	4.63e-05	0.000628	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	4.41e-05	0.000598	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	4.35e-05	0.000589	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—ITGB1—dilated cardiomyopathy	4.27e-05	0.000579	CbGpPWpGaD
Levothyroxine—SLCO1A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.03e-05	0.000546	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—GPX1—dilated cardiomyopathy	3.95e-05	0.000535	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—CD36—dilated cardiomyopathy	3.85e-05	0.000521	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—CD36—dilated cardiomyopathy	3.64e-05	0.000494	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	3.54e-05	0.00048	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—AGT—dilated cardiomyopathy	3.46e-05	0.000469	CbGpPWpGaD
Levothyroxine—SLCO1B1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.45e-05	0.000467	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—RAC1—dilated cardiomyopathy	3.43e-05	0.000465	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.42e-05	0.000464	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.4e-05	0.000461	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.33e-05	0.000452	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	3.33e-05	0.000451	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.32e-05	0.000449	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—RAF1—dilated cardiomyopathy	3.25e-05	0.00044	CbGpPWpGaD
Levothyroxine—TTR—Disease—EGFR—dilated cardiomyopathy	3.18e-05	0.000431	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—GPX1—dilated cardiomyopathy	3.1e-05	0.000421	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—CD36—dilated cardiomyopathy	3.02e-05	0.00041	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	3.01e-05	0.000408	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3e-05	0.000407	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.99e-05	0.000405	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	2.98e-05	0.000404	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	2.84e-05	0.000385	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—AGT—dilated cardiomyopathy	2.72e-05	0.000369	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—GPX1—dilated cardiomyopathy	2.65e-05	0.00036	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—CD36—dilated cardiomyopathy	2.58e-05	0.00035	CbGpPWpGaD
Levothyroxine—ABCB1—heart—dilated cardiomyopathy	2.5e-05	0.0165	CbGeAlD
Levothyroxine—SLCO1B1—Metabolism—AGT—dilated cardiomyopathy	2.33e-05	0.000315	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—RAF1—dilated cardiomyopathy	2.28e-05	0.000308	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—EGFR—dilated cardiomyopathy	2.23e-05	0.000302	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.97e-05	0.000267	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.73e-05	0.000234	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	1.52e-05	0.000207	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GPX1—dilated cardiomyopathy	1.52e-05	0.000205	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	1.48e-05	0.000201	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CD36—dilated cardiomyopathy	1.48e-05	0.0002	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	1.34e-05	0.000181	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—AGT—dilated cardiomyopathy	1.33e-05	0.00018	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	1.33e-05	0.00018	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CD36—dilated cardiomyopathy	1.29e-05	0.000175	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—AGT—dilated cardiomyopathy	1.16e-05	0.000158	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	8.18e-06	0.000111	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	7.97e-06	0.000108	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	7.18e-06	9.73e-05	CbGpPWpGaD
